Drugs ten years later: Epirubicin
- 1 May 1993
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 4 (5) , 359-369
- https://doi.org/10.1093/oxfordjournals.annonc.a058514
Abstract
G. Bonadonna, L. Gianni, A. Santoro, V. Bonfante, P. Bidoli, P. Casali, R. Demicheli, P. Valagussa; Drugs ten years later: Epirubicin, Annals of Oncology, VoluThis publication has 72 references indexed in Scilit:
- Phase II study of epirubicin sequential methotrexate and 5-fluorouracil for advanced colorectal cancerEuropean Journal Of Cancer, 1992
- Activity of high-dose epirubicin in advanced non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI Journal of the National Cancer Institute, 1990
- Weekly adriamycin® vs. 4-epidoxorubicin every second week in advanced breast cancer. A randomized trialEuropean Journal of Cancer and Clinical Oncology, 1990
- A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer: EORTC-GU group protocol 30867European Journal of Cancer and Clinical Oncology, 1989
- Effective palliation of advanced breast cancer with weekly low dose epirubicinEuropean Journal of Cancer and Clinical Oncology, 1989
- Non-hodgkin's lymphoma in Saudi Arabia: Prognostic factors and an analysis of the outcome of combination chemotherapy only, for both localized and advanced diseaseEuropean Journal of Cancer and Clinical Oncology, 1988
- Dose-effect and structure-function relationships in doxorubicin cardiomyopathyAmerican Heart Journal, 1981
- Dose-Response Effect of Adjuvant Chemotherapy in Breast CancerNew England Journal of Medicine, 1981
- Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moietyChemico-Biological Interactions, 1977